PHEOCHROMOCYTOMA ASSOCIATED WITH PRIOR CAROTID-BODY TUMORS (CHEMODECTOMAS) - DETECTION WITH I-131 METAIODOBENZYLGUANIDINE

被引:3
|
作者
CAMPEAU, RJ
GRAVES, C
机构
[1] TULANE UNIV,MED CTR,DEPT INTERNAL MED,NEW ORLEANS,LA 70112
[2] NORTHSHORE REG MED CTR,DEPT INTERNAL MED,SLIDELL,LA
关键词
D O I
10.1097/00003072-199107000-00012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Chemodectomas (carotid body tumors) were surgically removed on two occasions, first 10 years and then 3 months prior to detection with I-131 MIBG of an adrenal pheochromocytoma in a 32-year-old man with a family history of chemodectoma. Recent reports suggest patients with multiple and/or familial instances of chemodectoma frequently have associated catecholamine-secreting tumors detectable with I-131 or I-123 MIBG. This case documents the above association and suggests that any patient with proven carotid body tumor(s) be screened for catecholamine-secreting tumors via urinary/plasma catecholamine determinations.
引用
收藏
页码:511 / 512
页数:2
相关论文
共 50 条
  • [31] UNSUCCESSFUL I-131 METAIODOBENZYLGUANIDINE IMAGING OF CARCINOID-TUMORS AND APUDOMAS
    SINZINGER, H
    RENNER, F
    GRANEGGER, S
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (07) : 1221 - 1222
  • [32] METASTATIC PHEOCHROMOCYTOMA WITH A LONG-TERM RESPONSE AFTER I-131 METAIODOBENZYLGUANIDINE THERAPY
    PUJOL, P
    BRINGER, J
    FAUROUS, P
    JAFFIOL, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1995, 22 (04): : 382 - 384
  • [33] DETECTION OF METASTATIC SITES OF THYROID MEDULLARY CANCER USING I-131 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE)
    HASHIMOTO, T
    KUBO, A
    NAKAMURA, K
    HASHOMOTO, S
    ITO, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 681 - 681
  • [34] DOSIMETRY IN METABOLIC RADIOTHERAPY USING I-131 META-I/DOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) FOR NEUROBASTOMA AND PHEOCHROMOCYTOMA
    LUMBROSO, J
    AUBERT, B
    RICARD, M
    DIPAOLA, M
    SCHLUMBERGER, M
    PARMENTIER, C
    DIPAOLA, R
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 1008 - 1008
  • [35] RADIONUCLIDE DIAGNOSIS AND THERAPY OF NEURAL CREST TUMORS USING I-131 METAIODOBENZYLGUANIDINE
    HOEFNAGEL, CA
    VOUTE, PA
    DEKRAKER, J
    MARCUSE, HR
    JOURNAL OF NUCLEAR MEDICINE, 1987, 28 (03) : 308 - 314
  • [36] PREOPERATIVE LOCALIZATION OF PHEOCHROMOCYTOMA - A PROSPECTIVE COMPARISON OF I-131 METAIODOBENZYLGUANIDINE AND ABDOMINAL COMPUTED-TOMOGRAPHY
    BRAVO, EL
    SAHA, G
    GO, R
    ODONNELL, J
    JOURNAL OF HYPERTENSION, 1989, 7 : S354 - S354
  • [37] Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma
    Fujita, A
    Hyodoh, H
    Kawamura, Y
    Kanegae, K
    Furuse, M
    Kanazawa, K
    CLINICAL NUCLEAR MEDICINE, 2000, 25 (06) : 440 - 442
  • [38] CALCULATING RADIATION ABSORBED DOSE FOR PHEOCHROMOCYTOMA TUMORS IN I-131 MIBG THERAPY
    KORAL, KF
    WANG, XH
    SISSON, JC
    BOTTI, J
    MEYER, L
    MALLETTE, S
    GLAZER, GM
    ADLER, RS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (01): : 211 - 218
  • [39] TREATMENT PLANNING FOR I-131 METAIODOBENZYLGUANIDINE RADIOTHERAPY OF NEURAL CREST TUMORS USING I-124 METAIODOBENZYLGUANIDINE POSITRON EMISSION TOMOGRAPHY
    OTT, RJ
    TAIT, D
    FLOWER, MA
    BABICH, JW
    LAMBRECHT, RM
    BRITISH JOURNAL OF RADIOLOGY, 1992, 65 (777) : 787 - 791
  • [40] METASTASES FROM CARCINOID-TUMORS VISUALIZED BY I-131 METAIODOBENZYLGUANIDINE - REPORT OF 5 CASES
    MEY, P
    MINIER, JF
    ANNALES DE RADIOLOGIE, 1990, 33 (4-5) : 237 - 239